Pictet Asset Management (UK)’s Regenxbio RGNX Stock Holding History

Pictet Asset Management (UK)’s Portfolio RGNX Stock Details RGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-28,535	Closed	-$924K	–	1199
2020 Q1	$924K	Buy	+28,535	New	+$1.19M	﹤0.01%	947
2016 Q3	–	Sell	-285,420	Closed	-$3.53M	–	847
2016 Q2	$3.53M	Buy	285,420 +249,720	+699%	+$2.77M	0.01%	652
2016 Q1	$433K	Hold	35,700	–	–	﹤0.01%	796
2015 Q4	$593K	Hold	35,700	–	–	﹤0.01%	807
2015 Q3	$787K	Buy	+35,700	New	+$911K	﹤0.01%	804

Other funds holding RGNX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

ACM

Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pictet Asset Management (UK)'s RGNX Position: Q2 2020 in Review

Pictet Asset Management (UK) sold out of Regenxbio (RGNX) in Q2 2020, closing a stake of 28,535 shares — an estimated $924K sold.

Pictet Asset Management (UK) first reported a position in RGNX in Q3 2015 and held it in 5 quarters. The position peaked at $3.53M in Q2 2016. 179 funds tracked by Wall St. Rank hold RGNX as of Q2 2020.

Pictet Asset Management (UK) reported no remaining Regenxbio position as of Q2 2020 after selling out during the quarter.
Pictet Asset Management (UK) sold 28,535 Regenxbio shares in Q2 2020, an estimated $924K.
Pictet Asset Management (UK) first reported a position in Regenxbio in Q3 2015 and held it in 5 quarters.
Pictet Asset Management (UK)'s Regenxbio position peaked at $3.53M in Q2 2016.
179 funds tracked by Wall St. Rank held Regenxbio as of Q2 2020.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2020, filed 13 Aug 2020.